OPDIVO 10 mg/mL concentrate for solution for infusion

Company
Bristol-Myers Squibb Pharma EEIG
Active Ingredient
Strength
  • 10 mg
Dosage Form
Concentrate for solution for infusion
Legal Category
A - prescription, may not be renewed
Last Updated
25/09/2026
Licence number Strength ATC Code Dosage Form
EU/1/15/1014/001 10 mg QL01XC17 Concentrate for solution for infusion
EU/1/15/1014/002 10 mg QL01XC17 Concentrate for solution for infusion
EU/1/15/1014/003 10 mg QL01XC17 Concentrate for solution for infusion
EU/1/15/1014/004 10 mg QL01XC17 Concentrate for solution for infusion
Licence number
EU/1/15/1014/001
Strength
10 mg
ATC Code
QL01XC17
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/15/1014/002
Strength
10 mg
ATC Code
QL01XC17
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/15/1014/003
Strength
10 mg
ATC Code
QL01XC17
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/15/1014/004
Strength
10 mg
ATC Code
QL01XC17
Dosage Form
Concentrate for solution for infusion

Bristol-Myers Squibb Pharma EEIG

Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867, Ireland

Telephone
+3531800749749
Email
medical.information@bms.com